![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Corporate information
Registration country
Company type
Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases.Funding rounds
Series A USD 20,000,000
USD 20,000,000 ( )
| Investor | Profile | Country | |
|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Aescap Venture Management BV | Venture capital company investing in private medical companies in Europe | |
|
Novo A/S | ||
|
Sunstone Capital AS |
Investment activity status
Active investor